
Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
Advertisement
Articles by Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute

Advertisement
Latest Updated Articles
Rapid Readouts: Phase 1/2 KRYSTAL-1 TrialNovember 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma
2
FDA Accepts sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis
3
Beyond the Target: Payloads, Therapeutic Windows, and Biomarkers Shape the Next Wave of ADCs in NSCLC
4
Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC
5
